New HPV vaccine shows promise in protecting young girls and women
NCT ID NCT06632912
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental HPV vaccine in 1,800 females aged 9 to 35. The goal is to see if giving two doses to girls aged 9-14 works as well as three doses in older girls and women. Participants receive the vaccine in their upper arm and have several visits to check their immune response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV (HUMAN PAPILLOMAVIRUS)-ASSOCIATED CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Daiyue District Center for Disease Control and Prevention
Tai’an, Shandong, China
-
Liaocheng Center for Disease Control and Prevention
Liaocheng, Shandong, China
-
Shanxian Center for Disease Control and Prevention
Heze, Shandong, China